PetMedix
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Building 940 Babraham Research Campus, B...Phone Number
+44 1223734140Website
www.petmedix.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PetMedix
PetMedix is a research and development stage biopharmaceutical company developing antibody-based therapeutics for companion animals.PetMedix is located in the United KingdomExplore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PetMedix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if PetMedix is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at PetMedix
Product Launch: Get notified when PetMedix launches new products
Website visits: Recent activity has been detected on your website
Check if PetMedix has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on PetMedix recently announced quarterly report
Click to see if PetMedix had a recent Job posting/layoffs
PetMedix, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once PetMedix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to PetMedix
Compare insights from companies similar to PetMedix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PetMedix
<$5M
11-50
Private
$37M
2018
N/A
Company Profile Activity
Activity Insights
PetMedix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PetMedix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PetMedix.
PetMedix financials insights
Gather financial insights about PetMedix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$37M
PetMedix Tech Stack
A closer look at the technologies used by PetMedix
PetMedix News & Media
PetMedix raises USD37m in Series B round
PetMedix raises USD37m in Series B round Submitted 08/09/2021 - 10:10am PetMedix has completed an oversubscribed USD37 million (GBP27 million) Series B financing round that will be used to advance its innovative pipeline through clinical development. The investment brings two new investors into PetMedix: global technology company Tencent and Japanese corporation Kyoritsu Holdings alongside strong continued support from US-based investor Digitalis Ventures, and British funds Parkwalk Advisors andPetMedix: Bringing antibody therapies to cats and dogs
BioMed@Babraham biotech has early therapeutics for animals
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding PetMedix
Sign Up For FreeTo access detailed company insights
PetMedix is a research and development stage biopharmaceutical company developing antibody-based therapeutics for companion animals.PetMedix is located in the United Kingdom... Read More
